Takeda Pharmaceutical (TKPYY) Stock Down After U.S. Federal Jury Imposes $6 Billion In Damages

NEW YORK (TheStreet) -- Shares of Takeda Pharmaceutical Co.  (TKPYY) are down 4.52% to $22.25

The Japan-based company said it would fight $6 billion in punitive damages imposed by a U.S. federal jury in a case alleging the drugmaker concealed cancer risks associated with its Actos diabetes drug, Reuters reports.

Eli Lilly and Co, (LLY), Takeda's co-defendant in the case, was ordered to pay $3 billion in punitive damages.

Must Read: Warren Buffett's 10 Favorite Growth Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TKPYY Chart

TKPYY data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

General Motors Spikes on Report It's Considering Listing Shares of Cruise Unit

General Motors Spikes on Report It's Considering Listing Shares of Cruise Unit